<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Neoplasms</condition><disease>Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2509326</full_dataset_link><location>South Korea</location><study_start_month>9</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>The role of Gut ecosystem in obesity and colorectal patients</name><description>Interventions: Dietary Supplement : Intervention group
Brand name: Lacidofil 
Ingredient: contained L. rhamnosus R0011, L. acidophilus R0052 bacterial culture (2×109 colony-forming units), maltodextrin, magnesium stearate
dose: 1 capsule twice a day right after the meal
placebo
received placebo pills composed of maltodextrin, magnesium stearate, and ascorbic acid. The placebo was comparable in texture, taste, and color to the probiotics.
dose: 1 capsule twice a day right after the meal
Primary outcome(s): Irritable bowel symptom
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Outcome Accessor, Allocation : RCT</description><dates><creation>2012-09-15</creation></dates><accession>2509326</accession><cross_references><Clinical Research Information Service>KCT0001053</Clinical Research Information Service></cross_references></HashMap>